The credibility of the ACTOBAT follow-up study

被引：8

作者：

McCormick, MC ^{[1
]}

机构：

[1] HARVARD UNIV, SCH MED, JOINT PROGRAM NEONATOL, BOSTON, MA 02115 USA

来源：

PEDIATRICS | 1997年 / 99卷 / 03期

关键词：

D O I：

10.1542/peds.99.3.476

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：476 / 478

页数：3

共 9 条

[1] THYROTROPIN-RELEASING-HORMONE FOR PREVENTION OF NEONATAL RESPIRATORY-DISEASE [J].

BALLARD, RA ;

BALLARD, PL ;

CNAAN, A ;

PINTOMARTIN, J .

LANCET, 1995, 345 (8964) :1572-1572

[2] Australian Collaborative Trial of Antenatal Thyrotropin-Releasing Hormone: Adverse effects at 12-month follow-up [J].

Crowther, CA ;

Hiller, JE ;

Haslam, RR ;

Robinson, JS ;

Giles, W ;

Gill, A ;

Walters, W ;

Rowley, M ;

Evans, C ;

HendersonSmart, D ;

Child, A ;

Edwards, D ;

Ellwood, D ;

Downe, L ;

Cook, C ;

Chin, M ;

Arnold, J ;

Leslie, G ;

Smith, D ;

Fisher, C ;

Garvey, P ;

Chiltern, H ;

Peres, M ;

John, E ;

Trudinger, B ;

Roberts, S ;

Ballesty, J ;

Pesce, A ;

Nicholl, M ;

Likeman, R ;

Reynolds, G ;

Williams, M ;

Thomas, D ;

King, J ;

Tudehope, D ;

Stone, M ;

Johnson, W ;

Cartwright, D ;

Colditz, P ;

Forbes, K ;

Donovan, T ;

Hill, D ;

Bryce, R ;

Marshall, P ;

White, A ;

Wiadrowski, T ;

Hoby, M ;

Pridmore, B ;

Crowther, C ;

Haslam, R .

PEDIATRICS, 1997, 99 (03) :311-317

[3]

CROWTHER CA, 1995, LANCET, V345, P877

[4]

FLETCHER RH, 1982, CLIN EPIDEMIOLOGY ES, P192

[5]

FRANKENBURG WK, 1992, PEDIATRICS, V89, P91

[6]

GLASCOE FP, 1995, PEDIATRICS, V95, P829

[7]

McCormick M C, 1991, Paediatr Perinat Epidemiol, V5, P410, DOI 10.1111/j.1365-3016.1991.tb00727.x

[8]

MOYA FR, 1995, LANCET, V345, P1572

[9]

ZUCKERMAN BS, 1983, DEV BEHAV PEDIAT

← 1 →